遺伝薬理学 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "遺伝薬理学" in Japanese language version.

refsWebsite
Global rank Japanese rank
4th place
24th place
2nd place
6th place
1,538th place
2,886th place
low place
low place

dailyfinance.com

doi.org

  • Klotz, U. (2007). “The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.”. Clin Pharmacokinet 46 (4): 271–9. doi:10.2165/00003088-200746040-00001. PMID 17375979. 
  • Roses AD (June 2000). “Pharmacogenetics and the practice of medicine”. Nature 405 (6788): 857–65. doi:10.1038/35015728. PMID 10866212. 
  • “Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies”. JAMA 279 (15): 1200–5. (April 1998). doi:10.1001/jama.279.15.1200. PMID 9555760. 
  • “Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy”. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 360 (1460): 1563–70. (August 2005). doi:10.1098/rstb.2005.1685. PMC 1569528. PMID 16096104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569528/. 
  • “Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy”. JAMA 302 (8): 849–57. (August 2009). doi:10.1001/jama.2009.1232. PMID 19706858. 
  • “Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype”. Atherosclerosis 219 (1): 240–4. (November 2011). doi:10.1016/j.atherosclerosis.2011.06.005. PMC 3200506. PMID 21722898. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200506/. 
  • “DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity”. Cancer Chemother. Pharmacol. 67 (1): 49–56. (January 2011). doi:10.1007/s00280-010-1282-4. PMID 20204365. 

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Klotz, U. (2007). “The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.”. Clin Pharmacokinet 46 (4): 271–9. doi:10.2165/00003088-200746040-00001. PMID 17375979. 
  • Roses AD (June 2000). “Pharmacogenetics and the practice of medicine”. Nature 405 (6788): 857–65. doi:10.1038/35015728. PMID 10866212. 
  • “Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies”. JAMA 279 (15): 1200–5. (April 1998). doi:10.1001/jama.279.15.1200. PMID 9555760. 
  • “Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy”. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 360 (1460): 1563–70. (August 2005). doi:10.1098/rstb.2005.1685. PMC 1569528. PMID 16096104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569528/. 
  • “Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy”. JAMA 302 (8): 849–57. (August 2009). doi:10.1001/jama.2009.1232. PMID 19706858. 
  • “Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype”. Atherosclerosis 219 (1): 240–4. (November 2011). doi:10.1016/j.atherosclerosis.2011.06.005. PMC 3200506. PMID 21722898. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200506/. 
  • “DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity”. Cancer Chemother. Pharmacol. 67 (1): 49–56. (January 2011). doi:10.1007/s00280-010-1282-4. PMID 20204365. 

ncbi.nlm.nih.gov

unc.edu

pharmacy.unc.edu